Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism

S Bacon1, M P Kyithar1, E M Condron1

  • 1Department of Diabetes and Endocrinology, UCD School of Medicine, Mater Misericordiae University Hospital, 30, Eccles Street, Dublin 7, Ireland.

Acta Diabetologica
|August 25, 2016
PubMed
Abstract

Insights

HNF4A-MODY patients show prolonged hypoglycemia into adulthood due to a hyperinsulinaemic phase. This study tracked glucose and insulin secretion over six years, revealing key insights into this dual phenotype.

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Disorders

Background:

  • Hepatocyte nuclear factor 4 alpha (HNF4A) gene mutations cause maturity onset diabetes of the young (MODY).
  • HNF4A mutations are also linked to congenital hyperinsulinism, presenting a dual phenotype.
  • HNF4A-MODY exhibits hyperinsulinaemic hypoglycemia neonatally, progressing to diabetes in adulthood, but the transition is poorly understood.

Purpose of the Study:

  • To investigate the changes in glucose metabolism and insulin secretion over a six-year period in individuals with HNF4A-MODY.
  • To characterize glycaemic variability and hypoglycemia in HNF4A-MODY using continuous glucose monitoring systems (CGMS).

Main Methods:

  • An oral glucose tolerance test (OGTT) measuring glucose, insulin, and C-peptide was conducted in HNF4A participants with diabetes mellitus (DM), impaired glucose tolerance (IGT), and MODY-negative controls.
  • Serial assessments were performed in the HNF4A-IGT cohort.
  • Continuous glucose monitoring (CGM) was used for 72 hours in a subset of HNF4A-MODY mutation carriers.

Main Results:

  • No decline in glycaemic control was observed in the HNF4A-IGT cohort over the study period.
  • The HNF4A-IGT group exhibited significantly lower fasting glucose-to-insulin ratios compared to controls (0.13 vs. 0.24, p=0.03).
  • CGMS revealed prolonged hypoglycaemic episodes in the HNF4A-IGT group (432 min) compared to the HNF4A-DM group (138 min, p=0.04).

Conclusions:

  • Young adults with HNF4A-IGT maintain preserved glucose, insulin, and C-peptide secretory responses to oral glucose.
  • Prolonged hypoglycaemic periods are evident in HNF4A-IGT individuals, even in young adulthood (median age 21 years).
  • A persistent hyperinsulinaemic phase extending into adulthood is proposed as the cause of these hypoglycaemic episodes in HNF4A-MODY.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K